Oxidative Stress and Antioxidant Defense in Endometriosis and Its Malignant Transformation

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Iwabuchi, Takuya ^a   Yoshimoto, Chiharu ^b   Shigetomi, Hiroshi ^b   Kobayashi, Hiroshi ^b  

^a Metallogenics Co   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; HEMOGLOBIN; IRON COMPOUNDS; OXIDATION; OXIDATIVE STRESS; PORPHYRINS;

ANTIOXIDANT DEFENSE; BALANCE FUNCTIONS; ENGLISH LANGUAGES; FENTON REACTIONS; GLUTATHIONE TRANSFERASE; MALIGNANT TRANSFORMATIONS; OVARIAN CANCERS; REACTIVE OXYGEN SPECIES;

ANTIOXIDANTS;

ANTIOXIDANT; CYTOCHROME P450; FERRIC ION; FERROUS ION; GLUTATHIONE TRANSFERASE; HEME; HEME OXYGENASE; IRON DERIVATIVE; METHEMOGLOBIN; OXYHEMOGLOBIN; REACTIVE OXYGEN METABOLITE; HEME OXYGENASE 1; IRON;

AUTOOXIDATION; CELL DEATH; DNA DAMAGE; ENDOMETRIOSIS; FEMALE; FENTON REACTION; GENE EXPRESSION; HUMAN; INVESTIGATIVE PROCEDURES; MALIGNANT TRANSFORMATION; MEDLINE; OVARY CANCER; OXIDATIVE STRESS; REVIEW; METABOLISM; OVARIAN NEOPLASMS; PATHOLOGY;

ANTIOXIDANTS; ENDOMETRIOSIS; FEMALE; HEME; HEME OXYGENASE-1; HUMANS; IRON; OVARIAN NEOPLASMS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84936797697     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/848595     Document Type: Review

References (47)

1. H. Kobayashi, S. Imanaka, H. Nakamura, and A. Tsuji, "Understanding the role of epigenomic, genomic and genetic alterations in the development of endometriosis," Molecular Medicine Reports, vol. 9, no. 5, pp. 1483-1505, 2014.
2. M. A. Aon, S. Cortassa, and B. O'Rourke, "Redox-optimized ROS balance: A unifying hypothesis," Biochimica et Biophysica Acta, vol. 1797, no. 6-7, pp. 865-877, 2010.
3. E. Nagababu and J. M. Rifkind, "Heme degradation by reactive oxygen species," Antioxidants and Redox Signaling, vol. 6, no. 6, pp. 967-978, 2004.
4. K. Yamaguchi, M. Mandai, S. Toyokuni et al., "Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress," Clinical Cancer Research, vol. 14, no. 1, pp. 32-40, 2008.
5. Y. Higashiura, H. Kajihara, H. Shigetomi, and H. Kobayashi, "Identification of multiple pathways involved in the malignant transformation of endometriosis," Oncology Letters, vol. 4, no. 1, pp. 3-9, 2012.
6. C. P. Turner,M. Bergeron, P. Matz et al., "Heme oxygenase-1 is induced in glia throughout brain by subarachnoid hemoglobin," Journal of Cerebral Blood FlowandMetabolism, vol. 18,no. 3, pp. 257-273, 1998.
7. V. Chobot and F. Hadacek, "Iron and its complexation by phenolic cellular metabolites: from oxidative stress to chemical weapons," Plant Signaling and Behavior, vol. 5, no. 1, pp. 4-8, 2010.
8. D. G. Smith, R. Cappai, and K. J. Barnham, "The redox chemistry of the Alzheimer's disease amyloid peptide," Biochimica et Biophysica Acta, vol. 1768, no. 8, pp. 1976-1990, 2007.
9. D. Hare, S. Ayton, A. Bush, and P. Lei, "A delicate balance: iron metabolism and diseases of the brain," Frontiers in Aging Neuroscience, vol. 5, article 34, 2013.
10. V. Jeney, J. W. Eaton, G. Balla, and J. Balla, "Natural history of the bruise: formation, elimination, and biological effects of oxidized hemoglobin," Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID703571, 9 pages, 2013.
11. B. Uttara, A. V. Singh, P. Zamboni, and R. T. Mahajan, "Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options," Current Neuropharmacology, vol. 7, no. 1, pp. 65-74, 2009.
12. C. Yoshimoto, T. Iwabuchi, H. Shigetomi, and H. Kobayashi, "Cyst fluid iron-related compounds as useful markers to distinguish malignant transformation from benign endometriotic cysts," Cancer Biomarkers, vol. 15, no. 4, pp. 493-499, 2015.
13. I. Petrache, L. E. Otterbein, J. Alam, G. W. Wiegand, and A. M. K. Choi, "Heme oxygenase-1 inhibits TNF-alpha-induced apoptosis in cultured fibroblasts," The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 278, no. 2, pp. L312-L319, 2000.
14. S. V. S. Rana, "Metals and apoptosis: recent developments," Journal of Trace Elements in Medicine and Biology, vol. 22, no. 4, pp. 262-284, 2008.
15. R. K. Jones, R. F. Searle, and J. N. Bulmer, "Apoptosis and bcl-2 expression in normal human endometrium, endometriosis and adenomyosis," Human Reproduction, vol. 13, no. 12, pp. 3496-3502, 1998.
16. R. Gozzelino and M. P. Soares, "Coupling heme and iron metabolism via ferritin H chain," Antioxidants and Redox Signaling, vol. 20, no. 11, pp. 1754-1769, 2014.
17. J. L. Martin-Ventura, J. Madrigal-Matute, R. Martinez-Pinna et al., "Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: detoxifying mechanisms and potential therapeutic options," Thrombosis and Haemostasis, vol. 108, no. 3, pp. 435-442, 2012.
18. J. Sun, M. Brand, Y. Zenke, S. Tashiro, M. Groudine, and K. Igarashi, "Heme regulates the dynamic exchange of Bach1 and NF-E2-related factors in the Maf transcription factor network," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 6, pp. 1461-1466, 2004.
19. A. Van Langendonckt, F. Casanas-Roux,M.-M. Dolmans, and J. Donnez, "Potential involvement of hemoglobin and heme in the pathogenesis of peritoneal endometriosis," Fertility and Sterility, vol. 77, no. 3, pp. 561-570, 2002.
20. J. Wang and S. Doré, "Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage," Brain, vol. 130, no. 6, pp. 1643-1652, 2007.
21. J. J. Boyle, M. Johns, J. Lo et al., "Heme induces heme oxygenase 1 via Nrf2: role in the homeostatic macrophage response to intraplaque hemorrhage," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 11, pp. 2685-2691, 2011.
22. K. Nakahira, T. Takahashi, H. Shimizu et al., "Protective role of heme oxygenase-1 induction in carbon tetrachloride-induced hepatotoxicity," Biochemical Pharmacology, vol. 66, no. 6, pp. 1091-1105, 2003.
23. J. Liu, K. C. Wu, Y.-F. Lu, E. Ekuase, and C. D. Klaassen, "NRF2 protection against liver injury produced by various hepatotoxicants," Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 305861, 8 pages, 2013.
24. I. Pérez-de-Puig, A. Martń, R. Gorina, X. de la Rosa, E. Martinez, and A. M. Planas, "Induction of hemeoxygenase-1 expression after inhibition of hemeoxygenase activity promotes inflammation and worsens ischemic brain damage in mice," Neuroscience, vol. 243, pp. 22-32, 2013.
25. M. D. Hjorts and M. H. Andersen, "The expression, function and targeting of haem oxygenase-1 in cancer," Current Cancer Drug Targets, vol. 14, no. 4, pp. 337-347, 2014.
26. T. Leinders-Zufall, G. M. Shepherd, and F. Zufall, "Regulation of cyclic nucleotide-gated channels and membrane excitability in olfactory receptor cells by carbon monoxide," Journal of Neurophysiology, vol. 74, no. 4, pp. 1498-1508, 1995.
27. N. Hevir, M. Ribi?c-Pucelj, and T. Lani?snik Ri?zner, "Disturbed balance between phase I and II metabolizing enzymes in ovarian endometriosis: A source of excessive hydroxy-estrogens and ROS?" Molecular and Cellular Endocrinology, vol. 367, no. 1-2, pp. 74-84, 2013.
28. A. K. Singh, R. Chattopadhyay, B. Chakravarty, and K. Chaudhury, "Markers of oxidative stress in follicular fluid of women with endometriosis and tubal infertility undergoing IVF," Reproductive Toxicology, vol. 42, pp. 116-124, 2013.
29. H. Sova, J. Kangas, U. Puistola, M. Santala, A. Liakka, and P. Karihtala, "Down-regulation of 8-hydroxydeoxyguanosine and peroxiredoxin II in the pathogenesis of endometriosisassociated ovarian cancer," Anticancer Research, vol. 32, no. 8, pp. 3037-3044, 2012.
30. I. Szymczak, A. Sliwińska, and J. Drzewoski, "DNA damage and efficacy of DNA repair in patients with type 2 diabetes and coexisting colorectal cancer," Polskie Archiwum Medycyny Wewn?trznej, vol. 124, no. 7-8, pp. 352-358, 2014.
31. G. J. Beckett and J. D. Hayes, "Glutathione S-transferases: biomedical applications," Advances in Clinical Chemistry, vol. 30, pp. 281-380, 1993.
32. D. Agnani,O. Camacho-Vanegas, C. Camachoet al., "Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression," Journal of Ovarian Research, vol. 4, no. 1, article 18, 2011.
33. C. L. Zhu, Q. Huang, C. H. Liu, X. S. Lin, F. Xie, and F. Shao, "NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: A metaanalysis," Asian Pacific Journal of Cancer Prevention, vol. 14, no. 4, pp. 2349-2354, 2013.
34. S. Y. Hyun, H. I. Hwan, and Y. J. Jang, "Polo-like kinase-1 in DNA damage response," BMB Reports, vol. 47, no. 5, pp. 249-255, 2014.
35. H.-Y. Tang, L. A. Beer, T. Chang-Wong et al., "A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer," Journal of Proteome Research, vol. 11, no. 2, pp. 678-691, 2012.
36. B. Kong, C. Qia, M. Erkan, J. Kleeff, and C. W. Michalski, "Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels," Frontiers in Physiology, vol. 4, article 246, 2013.
37. H. Shigetomi,T. Sudo,K. Shimada et al., "Inhibition of cell death and induction of G2 arrest accumulation in human ovarian clear cells byHNF-1 transcription factor," International Journal of Gynecological Cancer, vol. 24, no. 5, pp. 838-843, 2014.
38. D. M. S. Lundvig, S. Immenschuh, and F. A. D. T. G. Wagener, "Heme oxygenase, inflammation, and fibrosis: The good, the bad, and the ugly?" Frontiers in Pharmacology, vol. 3, article 81, 2012.
39. M. Gutowski and S. Kowalczyk, "A study of free radical chemistry: Their role and pathophysiological significance," Acta Biochimica Polonica, vol. 60, no. 1, pp. 1-16, 2013.
40. D. Ivanova, R. Bakalova, D. Lazarova, V. Gadjeva, and Z. Zhelev, "The impact of reactive oxygen species on anticancer therapeutic strategies," Advances in Clinical and Experimental Medicine, vol. 22, no. 6, pp. 899-908, 2013.
41. M.-C. Kim, F.-J. Cui, and Y. Kim, "Hydrogen peroxide promotes epithelial to mesenchymal transition and stemness in human malignant mesothelioma cells," Asian Pacific Journal of Cancer Prevention, vol. 14, no. 6, pp. 3625-3630, 2013.
42. M. Marra, I. M. Sordelli, A. Lombardi et al., "Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: An overview," Journal of TranslationalMedicine, vol. 9, no. 1, article 171, 2011.
43. C. Mo, Y. Dai, N. Kang, L. Cui, and W. He, "Ectopic expression of human MutS homologue 2 on renal carcinoma cells is induced by oxidative stress with interleukin-18 promotion via p38 mitogen-activated protein kinase (MAPK) and c-Jun Nterminal kinase (JNK) signaling pathways," The Journal of Biological Chemistry, vol. 287, no. 23, pp. 19242-19254, 2012.
44. M. J. Worley Jr., W. R. Welch, R. S. Berkowitz, and S. W. Ng, "Endometriosis-associated ovarian cancer: A review of pathogenesis," International Journal of Molecular Sciences, vol. 14, no. 3, pp. 5367-5379, 2013.
45. M. Padurariu, A. Ciobica, R. Lefter, I. L. Serban, C. Stefanescu, and R. Chirita, "The oxidative stress hypothesis in Alzheimer's disease," Psychiatria Danubina, vol. 25, no. 4, pp. 401-409, 2013.
46. M. Varc?in,E. Bentea, Y. Michotte, and S. Sarre, "Oxidative stress in genetic mouse models of Parkinson's disease," Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 624925, 25 pages, 2012.
47. A. Anand, K. Thakur, and P. K. Gupta, "ALS and oxidative stress: The neurovascular scenario," Oxidative Medicine and Cellular Longevity, vol. 2013,Article ID 635831, 14 pages, 2013.